The Effect of n-3 LCPUFA on Immune Function and Cardiovascular Risk Factors

NCT00266292 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2010-05-28

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of long-chain n-3 polyunsaturated fatty acids (n-3 LCPUFA) on immune function and cardiovascular disease risk

Conditions

  • Cardiovascular Heart Disease
  • Metabolic Syndrome

Interventions

BEHAVIORAL

Fish oil (Bio-Marine, Pharma Nord)

BEHAVIORAL

n-6 PUFA intake (Margarine+sunflower oil vs. butter product+rapeseed oil)

Sponsors & Collaborators

  • Danish Research Agency

    collaborator OTHER
  • Hjerteforeningen

    collaborator UNKNOWN
  • Technical University of Denmark

    collaborator OTHER
  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Lotte Lauritzen, Ph.D · Department of Human Nutrition, Royal Veterinary and Agricultural University, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Completion
2006-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00266292 on ClinicalTrials.gov